IMDNA (Integrated Molecular Design of Nucleic Acids) is an innovation-driven biotechnology company focused on the molecular design of DNA and RNA systems for advanced biological research. Our work sits at the intersection of molecular microbiology, immunology, and nucleic-acid engineering.

We follow biology-first design principles to create precise, scalable molecular solutions informed by microbial genomics, host–pathogen interactions, and immune-response biology. By combining computational design with rigorous experimental validation, IMDNA delivers high-performance molecular components built for reliability, reproducibility, and consistent laboratory outcomes.

At IMDNA, innovation starts at the molecular level—where scientific insight, thoughtful design, and quality-driven execution come together to accelerate research in microbiology and immunology.